Ososayensi abavela ezinkampanini ezimbili bahlaziye ukulandelana kwe-SARS-CoV-2 Omicron ehlukile, ukulandelana kwegciwane okukhethiwe, kanye nama-clone e-plasmid aklanywe. Silindele ukuthi imithi yokugoma emisha ye-Omicron SARS-CoV-2 ingathuthukela ekuhlolweni komtholampilo esikhathini esingaphansi kwezinsuku eziyi-100.
“Sikholelwa ukuthi kubalulekile ukwenza imigomo emisha ngokushesha nangempumelelo ukuze kuliwe nokwehluka okusha kwe-Omicron COVID-19. Sizosebenzisana eduze nezinhlangano ezilawulayo futhi sifune izifundo zomtholampilo ezifanele kanye nezigunyazo zokulawula ukuze lethe lo mgomo emakethe ngokushesha okukhulu.” kusho uBrad Sorenson, oyi-CEO yeProvidence Therapeutics.
"Sibheke ngabomvu ukuthuthukisa ngokushesha lo mgomo omusha ohlukile we-Omicron nge-Providence, futhi ilethe inzuzo yalo mgomo kulezo zindawo ezifinyeleleka kancane ekwelashweni kwamanje komgomo we-mRNA." kuphawula u-Kerry Blanchard, MD, PhD, Isikhulu Esiphezulu se-Everest Medicines.
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- “Sibheke ngabomvu ukuthuthukisa ngokushesha lo mgomo omusha ohlukile we-Omicron nge-Providence, futhi ilethe inzuzo yalo mgomo kulezo zindawo ezifinyeleleka kancane ekwelashweni kwamanje komjovo we-mRNA ikakhulukazi.
- “Sikholelwa ukuthi kubalulekile ukwakha imigomo emisha ngokushesha nangempumelelo ukuze kuliwe nokwehluka okusha kwe-Omicron COVID-19.
- Sizosebenzisana eduze nezinhlangano ezilawulayo futhi sifune izifundo zomtholampilo ezifanele kanye nezigunyazo zokulawula ukuze silethe lo mgomo emakethe ngokushesha okukhulu.
